Skip to main content
. Author manuscript; available in PMC: 2014 Mar 23.
Published in final edited form as: J Rheumatol. 2013 Feb 15;40(4):461–468. doi: 10.3899/jrheum.120264

Table 1.

Positive sera against centromere protein (CENP)-P and -Q in systemic sclerosis (SSc) and other cohorts. Positives to CENP-P/-Q were determined by ELISA and Western blot methods. P value was calculated using Pearson’s chi-square or Fisher’s exact test. P values < 0.05 are shown in bold type, indicating statistically significant differences compared to anticentromere antibody (ACA)-positive.

Anti-CENP-P (+) Anti-CENP-Q (+)
Cohort Cases No. (%, p value) No. (%, p value)
SSc
  ACA+ 35 14 (40) 11 (31.4)
  ACA‒ 151 9 (6, < 0.0001) 0 (0, < 0.0001)
pSS (ACA+) 18 1 (5.6, 0.0207) 2 (11.1, 0.1771)
SLE (ACA+) 20 3 (15, 0.1038) 5 (25, 0.7608)
RA (ACA+) 13 2 (15.4, 0.1703) 0 (0, 0.0228)
PBC (ACA+) 18 5 (27.8, 0.5644) 1 (5.6, 0.0412)
Healthy (ACA‒) 31 0 (0, 0.0002) 0 (0, 0.0020)

SLE: systemic lupus erythematosus; pSS: primary Sjögren syndrome; RA: rheumatoid arthritis; PBC: primary biliary cirrhosis.